| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.51▼ | 0.51▼ | 0.52▼ | 0.53▼ | 0.52▼ |
| MA10 | 0.51▼ | 0.52▼ | 0.53▼ | 0.55▼ | 0.70▼ |
| MA20 | 0.52▼ | 0.52▼ | 0.52▼ | 0.54▼ | 1.09▼ |
| MA50 | 0.52▼ | 0.52▼ | 0.55▼ | 0.75▼ | 2.74▼ |
| MA100 | 0.52▼ | 0.55▼ | 0.54▼ | 1.14▼ | 6.53▼ |
| MA200 | 0.54▼ | 0.54▼ | 0.58▼ | 1.78▼ | 14.31▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.001▼ | 0.001▲ | 0.014▲ | 0.113▲ |
| RSI | 41.058▼ | 42.279▼ | 42.189▼ | 38.487▼ | 25.297▼ |
| STOCH | 63.661 | 12.009▼ | 47.508 | 28.336 | 4.737▼ |
| WILL %R | -73.810 | -87.172▼ | -62.162 | -74.038 | -94.936▼ |
| CCI | -81.019 | -89.875 | -36.430 | -58.891 | -82.763 |
|
Tuesday, April 29, 2025 09:00 AM
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept ...
|
|
Friday, April 25, 2025 10:15 AM
ALX Oncology (ALXO) announced “encouraging” data from an ongoing Phase 1/2 investigator-sponsored trial of the company’s lead clinical ...
|
|
Friday, April 25, 2025 07:48 AM
Currently, ALXO is trading at $0.58 down by 3.33 percent on the Nasdaq. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 0.5282 | 0.5393 | 0.5042 | 0.5157 | 269,515 |
| 30/04/25 | 0.5032 | 0.54 | 0.4923 | 0.54 | 390,242 |
| 29/04/25 | 0.511 | 0.5168 | 0.4917 | 0.5042 | 584,608 |
| 28/04/25 | 0.52 | 0.5642 | 0.5115 | 0.5303 | 427,897 |
| 25/04/25 | 0.5254 | 0.627 | 0.5254 | 0.5417 | 1,490,283 |
| 24/04/25 | 0.60 | 0.6383 | 0.583 | 0.601 | 362,549 |
| 23/04/25 | 0.615 | 0.66 | 0.5745 | 0.58 | 477,815 |
| 22/04/25 | 0.58 | 0.5973 | 0.5376 | 0.5929 | 427,883 |
| 21/04/25 | 0.5478 | 0.5736 | 0.531 | 0.5662 | 251,931 |
| 17/04/25 | 0.55 | 0.5768 | 0.541 | 0.55 | 337,512 |
|
|
||||
|
|
||||
|
|